Allianz Asset Management GmbH Has $91.99 Million Stock Holdings in Agilent Technologies, Inc. $A

Allianz Asset Management GmbH lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 10.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 676,024 shares of the medical research company’s stock after selling 77,425 shares during the period. Allianz Asset Management GmbH’s holdings in Agilent Technologies were worth $91,987,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Massachusetts Financial Services Co. MA lifted its position in shares of Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. Wellington Management Group LLP raised its holdings in Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after acquiring an additional 433,342 shares in the last quarter. Geode Capital Management LLC raised its holdings in Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Generation Investment Management LLP raised its holdings in Agilent Technologies by 10.1% in the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after acquiring an additional 582,093 shares in the last quarter. Finally, Norges Bank acquired a new position in Agilent Technologies in the 4th quarter valued at approximately $549,158,000.

Analyst Upgrades and Downgrades

Several research firms have commented on A. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and cut their price target for the company from $150.00 to $145.00 in a report on Thursday, May 28th. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Robert W. Baird upped their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Royal Bank Of Canada began coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. Finally, Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $161.71.

Agilent Technologies Stock Down 2.7%

NYSE A opened at $131.88 on Thursday. The firm has a market cap of $37.25 billion, a PE ratio of 26.48, a price-to-earnings-growth ratio of 2.41 and a beta of 1.26. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The stock’s 50 day simple moving average is $119.63 and its 200 day simple moving average is $128.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.99 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.